The 35th annual meeting of the photodermatology society

— will be held —

March 26, 2026
Embassy Suites Denver Downtown Convention Center
Crestone Ballroom B
1420 Stout Street
Denver, Colorado, USA 80202

Program

8:00 - 8:25 Registration and Social Time
8:25 – 8:30   Sunil Kalia, MD, MHSc, Vancouver, Canada
Photodermatology 2026: Innovations, Evidence and Controversy
New and Now: Innovations in Photodermatology
8:30 – 8:55 Sally Ibbotson, MD, Dundee, Scotland, United Kingdom
Photosensitivity and the Role of Photodiagnostic Services
8:55 – 9:20 Stephen Shumack, MD, Sydney, Australia
When Sunscreen Testing Becomes Scandalous
9:20 – 9:30 Q&A
American Society for Photobiology Lecture
9:30 – 9:55 Masaoki Kawasumi, MD, PhD, Columbus, Ohio
Beyond Sunscreens: Caffeine as a Molecular Strategy for UV-Induced Skin Cancer Prevention
9:55 – 10:00    Q&A
10:00 – 10:15 Break
“Come See My Poster” Presentations
10:15 – 10:17 Carli Tucci, BS, New York, New York
Factors Associated with Phototherapy Adherence in a Large Single- Institution Cohort
10:18 – 10:20 Chenan A. Huang, MD, Winston-Salem, North Carolina
A Framework for Reconsidering Universal Sunscreen Recommendations in Favor of Holistic, Personalized Guidelines that Consider Medical History, Comorbidities, Age, and Mortality Risk
10:21 – 10:23 Erika McCormick, MD, New York, New York
Topical Nanoencapsulated Cannabidiol Cream as an Innovative Strategy Combating UV-A-Induced Nuclear and Mitochondrial DNA Injury: A Pilot Randomized Clinical Study
10:24 – 10:26 Umayr R. Shaikh, MPH, Philadelphia, Pennsylvania
When MED Trends, Colorimetry Reveals: Quantitative Detection of Nutritional Photoprotection
10:27 – 10:29 Yu Xuan (Rita) Jin, HBSc, Vancouver, Canada
Twenty-year Epidemiologic Analysis of Cutaneous Melanoma in British Columbia
10:30 – 10:32 Robert Gadow, MD, Duesseldorf, Germany
A Two-Year Follow-Up Of EPP Patients During Afamelanotide Treatment Indicates Increases in the Quality Of Life, Time Spent Outside and Demasking of Pre-Existing Pigmented Lesions
10:33 – 10:35 Emily Sirotich, PhD, New Haven, Connecticut
Occupational Sun Exposure Experienced by Firefighting Personnel in Colorado: A Survey Study
10:36 – 10:38 Kamryn Abraskin, MM, Detroit, Michigan
Over-the-Counter Red-Light and Near-Infrared Devices: Analysis and Understanding of Spectral Output
10:39 – 10:41 Rebecca L. Quiñonez, MD, MS, Detroit, Michigan
Visible Light-Induced Clinical and Transcriptomic Alterations in Diverse Skin Phototypes
Oral Abstract Presentations
10:42 – 10:52 Benoit Canolle, PhD, Paris, France
Safe and Long-Lasting Bioadhesive UVA and UVB Filters: The Future Generation of
Non-penetrating UV filters With Persistent Efficacy Overtime
10:53 – 11:03 Zasca-Aisha Ristianto, BS, New York, New York
Skin of Color is Associated with Lower Rates of Adverse Events Without Compromising Phototherapy Efficacy
11:04 – 11:14 Yang Yang, BS, Cleveland, Ohio
Carbon Nanomaterials as Next-Generation Active Ingredients for Safer and More Effective Photoprotection
11:15 – 11:20 Trainee Abstract Competition Winner Presentation
Elisabeth Richard, MD, Baltimore, Maryland
11:20 – 11:45 Poster Viewing
11:45 – 1:00   Break for Lunch
Keynote Speaker
1:00 – 1:45   Piergiacomo Calzavara Pinton, MD, and Mariateresa Rossi, MD, Brescia, Italy
The Realistic Positioning of Phototherapy at the Age of Biologics
1:45 – 2:00 Q&A
2:00 – 2:15 Break
Photoprotection
2:15 – 2:20 Introduction
Steven Wang, MD, Newport Beach, California
2:20 – 2:40   Yolanda Gilaberte, MD, Zaragoza, Spain
Balancing Risk and Benefit: The Positive Effects of Sunlight on Human Health
2:40 – 3:00 Curtis Cole, PhD, New York, New York
The Impact of Visible Light Protection on Real Sunlight SPF
3:00 – 3:10   Q&A
3:10 – 3:25   Break
3:25 – 3:45 Carl D’Ruiz, MPH, Parsippany, New Jersey
Breaking the 26-Year Barrier: BEMT Becomes the First New GRASE Sunscreen in the FDA Monograph!
3:45 – 4:05   Indermeet Kohli, PhD, Detroit, Michigan
Updates on Impact of Visible Light on Human Skin
4:05 – 4:20   Tania K. Hernandez, BS, New York, New York
Evaluation of a Sunscreen Resistance Under Elevated Heat and Humidity Using a Controlled Chamber in Diverse Individuals
4:20 – 4:30    Q&A